drugset / Trial / NCT03202524

Fresh Frozen Plasma as a Substitute for Albumin in Patients Receiving a Large Volume Paracentesis

NCT03202524

Phase 4 Withdrawn Montefiore Medical Center
RandomizedParallel-groupOpen-labelTreatment

Summary

Large volume paracentesis with albumin administration is the standard of care for patients with refractory ascites complicating end-stage liver disease. However, the use of albumin is frequently limited due to expense and occasional short supply. The goal of this study is to demonstrate if the administration of fresh frozen plasma (FFP) is as effective as albumin for volume expansion at the time of a large volume paracentesis.

Timeline

Start
2017-12
Primary completion
2018-07
Completion
2018-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Albumin Protein / enzyme biologic 50 ml
Subject Fresh Frozen Plasma Protein / enzyme biologic 2 unknown

Indications